The global interventional radiology (IR) market, valued at USD 30.34 billion in 2025, is forecasted to reach USD 49.43 billion by 2035, growing at a compound annual growth rate (CAGR) of 5.2%, according to a newly released industry outlook. This growth underscores the increasing adoption of minimally invasive, image-guided procedures across key regions including APAC, Europe, the USA, and Saudi Arabia.
Interventional radiology has transformed modern healthcare by enabling targeted therapies with precision and minimal patient discomfort. Central venous access procedures alone account for nearly 40% of all IR interventions in Europe, demonstrating the pivotal role of these techniques in both acute and chronic care. Advanced imaging allows interventional radiologists to deliver medications, fluids, and nutrition directly into the bloodstream, minimizing repeated invasive procedures and improving recovery outcomes.
Explore trends before investing — request a sample report today!:- https://www.futuremarketinsights.com/reports/sample/rep-gb-14344
Market Dynamics and Technological Advancements
The global IR market has expanded significantly due to continuous advancements in catheter-based technologies, imaging modalities, and specialized medical devices. Innovations in robotics, artificial intelligence (AI), and real-time navigation software have elevated procedural accuracy, minimized risks, and streamlined clinical workflows. Leading companies such as Siemens Healthineers, GE Healthcare, Philips Healthcare, Canon Medical Systems, Intuitive Surgical, and Robocath are at the forefront of integrating these smart technologies.
Regional Insights
In North America, the United States remains the largest market, projected to grow at a CAGR of 2.3% through 2035, driven by a 92% patient preference for minimally invasive procedures. Germany, leading Western Europe, shows a CAGR of 2.0%, benefiting from robust regulatory frameworks, advanced imaging systems, and strong reimbursement policies. In APAC, India is projected to record the highest growth with a CAGR of 7.4%, fueled by rising medical tourism, healthcare infrastructure investments, and the increasing prevalence of chronic diseases. China follows closely with a 6.9% CAGR, reflecting strong technological adoption and expanding patient demand.
Emerging Applications Drive Market Expansion
Interventional oncology (IO) has emerged as a key growth driver, with image-guided tumor ablations, embolization therapies, and palliative procedures providing alternatives to traditional cancer care. Similarly, minimally invasive reproductive treatments such as uterine fibroid embolization (UFE), pelvic venous congestion syndrome treatment, and prostate artery embolization (PAE) are rapidly gaining traction due to lower procedural risks, reduced recovery times, and fertility preservation advantages.
Integration of AI and Robotics
AI-powered imaging, automated lesion recognition, and robotic-assisted navigation are redefining procedural efficiency and clinical outcomes. Simulation-to-reality (Sim2Real) technologies allow specialists to practice complex interventions virtually, enhancing skill levels and standardizing care. Robotic automation also offers opportunities for tele-operated IR procedures, potentially expanding access to advanced care in underserved regions.
Challenges and Market Constraints
Despite strong growth, the IR market faces constraints including a shortage of highly trained specialists and significant learning curves associated with complex procedures. Variability in training standards across regions continues to impact procedural efficiency and adoption rates, particularly in emerging markets.
Product and Procedure Segmentation
MRI systems dominate the IR equipment segment with a 30.5% share in 2025, valued for superior soft tissue imaging and broad diagnostic applications. Angioplasty procedures are the leading indication, accounting for 23.7% of the procedural market, reflecting increasing prevalence of cardiovascular diseases worldwide.
Click Here to Purchase the Report:- https://www.futuremarketinsights.com/checkout/14344
Competitive Landscape
The IR market is highly competitive, with Tier 1 companies holding 33.5% of the global share, focusing on strategic collaborations and innovation. Tier 2 players account for 29.1%, targeting emerging clinical needs and promoting accessibility. Recent strategic partnerships, such as AGFA HealthCare with Rad AI and Canon Medical Systems with ScImage, highlight the sector’s rapid technological evolution.
Future Outlook
From 2025 to 2035, the IR market is projected to maintain strong momentum, driven by technological breakthroughs, rising patient demand for minimally invasive treatments, and the integration of AI and robotics. Expanding applications across oncology, cardiology, neurology, and reproductive health, combined with enhanced training programs, will continue to shape a resilient and rapidly evolving global market.
Why Choose FMI Empowering Decisions that Drive Real-World Outcomes:- https://www.futuremarketinsights.com/why-fmi
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: [email protected]
Website: https://www.futuremarketinsights.com
